Insulet reports 18 serious adverse events with recall of Omnipod 5 insulin pumps

Insulet is recalling specific lots of its Omnipod 5 insulin patch pumps due to a small tear in the internal tubing that can lead to insulin leaking inside the pod, causing under-delivery. The company has reported 18 serious adverse events, including hospitalizations and diabetic ketoacidosis, but no deaths. Insulet anticipates up to $40 million in recall-related costs for 2026 but maintains its revenue growth expectations.